Search Results 541-550 of 18144 for Myopathy

  1. Movement disorders - Doctors and departments - Mayo Clinic

    ... Myopathy. Show more areas of focus for Billie A. Schultz, M.D.. Daniel B. Wei, M.D.. Physiatrist. Phoenix, AZ. Areas of focus: Botox ...

  2. Lomitapide (oral route) - Side effects & dosage - Mayo Clinic

    Using this medicine together with lovastatin or simvastatin may increase risk of a serious muscle problem called myopathy. Check with your doctor right away ...

  3. Movement disorders - Doctors and departments - Mayo Clinic

    ... Myopathy, Gait disturbance, Cerebral palsy, Movement disorder, Balance problem, Head and brain injury, Parkinson's disease, Dystonia, Foot drop ...

  4. Movement disorders - Doctors and departments - Mayo Clinic

    ... Myopathy, Gait disturbance, Cerebral palsy, Movement disorder, Balance problem, Head and brain injury, Parkinson's disease, Dystonia, Foot drop ...

  5. Spinal cord injury - Doctors and departments - Mayo Clinic

    ... Myopathy, Guillain Barre syndrome, Spasticity, Myelopathy, Paraplegia, Neurogenic bladder dysfunction, Quadriplegia, Demyelinating neuropathy, Neuropathy ...

  6. Congenital Metabolic Disorder Clinical Trials - Mayo Clinic Research

    To establish a repository of DNA samples collected prospectively from patients with inherited myopathies of unknown molecular and/or biochemical defect. To ...

  7. Movement disorders - Doctors and departments - Mayo Clinic

    ... Myopathy. Show more areas of focus for Billie A. Schultz, M.D.. Daniel B. Wei, M.D.. Physiatrist. Phoenix, AZ. Areas of focus: Botox ...

  8. Neurosurgery - Clinical trials

    To establish a repository of DNA samples collected prospectively from patients with inherited myopathies of unknown molecular and/or biochemical defect. To ...

  9. Neurology - Doctors - Mayo Clinic

    Electrodiagnostic Physician. Jacksonville, FL. Areas of focus: Electromyography, Myasthenia gravis, Neuropathy, Motor neuron disease, Myopathy ...

  10. A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) - Mayo Clinic

    assessments. 13. Diagnosis of immune-mediated necrotizing myopathy (IMNM) [(positive 3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGR), anti ...